Lonza Group AG

Common Name
Lonza Group
Country
Switzerland
Sector
Healthcare
Industry
Diagnostics & Research
Employees
19,299
Ticker
LONN
Exchange
SIX SWISS EXCHANGE
Description
Lonza Group AG is a prominent multinational chemical and biotechnology company. It primarily focuses on the development and manufacture of products and services for the pharmaceutical, biotechnology, ...

Financial Statements of Lonza Group

Below are the financial statements of Lonza Group, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

All figures in millions of CHF20242023
Sales
6,574a
6,717a
Cost of goods sold
-4,414a
-4,769a
Gross profit
2,160a
1,948a
Marketing and distribution
-259a
-237a
Research and development
-118a
-105a
Administration and general overheads
-821a
-732a
Other operating income
113a
44a
Other operating expenses
-111a
-38a
Result from operating activities (EBIT)
964a
880a
Financial income
42a
50a
Financial expenses
-251a
-127a
Net financial result
-209a
-77a
Share of profit/(loss) of associates/joint ventures
-1a
-13a
Profit before income taxes
754a
790a
Income taxes
-117a
-135a
Profit for the period
637a
655a
Attributable to
Equity holders of the parent
636a
654a
Non-controlling interest
1a
1a
Download Data

Verified Sources Behind Lonza Group’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Lonza Group’s data sources below and access millions more through our Disclosure Search.

a. Lonza Group's Annual Report 2024
a. Lonza Group's Annual Report 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?